Franklin King, MD
Instructor, Mass General Hospital
Dr. King completed residency in psychiatry at MGH/McLean followed by a fellowship in Consult-Liaison (CL) Psychiatry at MGH and a research fellowship at the MGH Cardiac Psychiatry Research Program. His areas of research include optimization of therapy paradigms within psychedelic research as well as the use of psychedelic-assisted therapies in disorders at the mind-body interface. Dr. King is currently the Principal Investigator in a pilot study exploring the feasibility of psilocybin-assisted therapy for irritable bowel syndrome, Co-PI for a collaboration with Fireside Project, a national psychedelic harm reduction organization, and is the study psychiatrist for a neuroimaging study examining the effects of MDMA-assisted therapy for fibromyalgia. He is also co-developing the Harvard-wide Interdisciplinary Program in Psychedelics with colleagues at BWH and BIDMC, a program that provides education and training in psychedelic-assisted therapies for clinicians across the HMS community.
Conflicts of Interest: Compass - personal stock / Cybin - personal stock / Apex Labs - Scientific Advisory Board